Clinical Trials Browser

Phase 3 × NIH × Genitourinary × Clear all

NCT06524544 2026-05-27

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Phase 3 Recruiting

Carcinoma, Transitional Cell

NCT03793166 2026-05-13

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Lymphatic Metastasis

NCT04579224 2026-05-13

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

Phase 3 Active not recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05092958 2026-05-13

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Phase 3 Active not recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT01575548 2026-05-04

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Phase 3 Active not recruiting

129 enrolled 11 charts

Carcinoma, Renal Cell

NCT03055013 2026-05-04

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Phase 3 Active not recruiting

819 enrolled 12 charts

Carcinoma, Renal Cell

NCT03775265 2026-05-04

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Phase 3 Completed

506 enrolled 13 charts

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00326898 2022-02-08

ASSURE

Phase 3 Completed

1,943 enrolled 12 charts

Carcinoma, Renal Cell

NCT01198158 2019-03-06

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

Phase 3 Terminated

77 enrolled 11 charts

Carcinoma, Renal Cell

NCT00004635 2018-05-22

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Phase 3 Completed

159 enrolled 9 charts

Neoplasms, Prostatic Neoplasms

NCT00003734 2016-07-21

Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00003804 2014-06-24

Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor

Phase 3 Unknown

Kidney Neoplasms, Wilms Tumor

NCT00047138 2014-06-24

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

Phase 3 Unknown

Kidney Neoplasms, Wilms Tumor

NCT00110214 2014-05-09

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 3 Completed

1,050 enrolled 13 charts

Prostatic Neoplasms

NCT00767286 2014-01-28

Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00398281 2014-01-10

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00553124 2014-01-10

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00553345 2014-01-10

Selenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00053820 2013-12-19

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00002490 2013-12-18

Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00003814 2013-12-18

Eflornithine in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00024349 2013-12-18

Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00054626 2013-12-18

Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00003014 2013-12-04

Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer

Phase 3 Completed

Testicular Germ Cell Tumor, Testicular Neoplasms, Seminoma

NCT00003290 2013-12-04

Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00002703 2013-11-06

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00003725 2013-11-06

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00005075 2013-11-06

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00033436 2013-09-20

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

Phase 3 Unknown

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

NCT00363285 2013-08-26

Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00376792 2013-08-26

Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00324298 2013-08-12

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Phase 3 Completed

Testicular Germ Cell Tumor, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00492258 2013-08-12

Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00796458 2013-08-12

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Phase 3 Unknown

Pain, Prostatic Neoplasms

NCT01094964 2013-08-12

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Phase 3 Unknown

Urinary Bladder Neoplasms

NCT00110162 2013-08-07

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

Phase 3 Unknown

Prostatic Neoplasms

NCT00589537 2013-08-07

Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle

Phase 3 Unknown

Testicular Germ Cell Tumor, Testicular Neoplasms, Seminoma

NCT00632138 2013-08-07

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

Phase 3 Completed

GenitourinaryOther

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

Phase 3 Unknown

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

NCT00005590 2013-08-02

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Phase 3 Completed

BreastCNSDermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmThoracic

Testicular Germ Cell Tumor, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Lung Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mycosis Fungoides, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Small Cell Lung Carcinoma, Intraocular Lymphoma

NCT00002596 2013-06-26

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Phase 3 Completed

Teratoma, Testicular, Testicular Germ Cell Tumor, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00082927 2013-06-26

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain

Phase 3 Completed

Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT00255606 2013-06-26

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00316927 2013-06-26

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00018941 2013-06-17

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00006034 2013-05-15

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms

NCT00005623 2013-03-26

Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms, Hot Flashes

NCT00002723 2013-02-28

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms